Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Total Receivables Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Receivables
$36.5m
CAGR 3-Years
55%
CAGR 5-Years
136%
CAGR 10-Years
80%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Total Receivables
CA$110.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Total Receivables
$10.7m
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
60%
Repare Therapeutics Inc
NASDAQ:RPTX
Total Receivables
$15.3m
CAGR 3-Years
35%
CAGR 5-Years
69%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Total Receivables
CA$6.3m
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
20%
Spectral Medical Inc
TSX:EDT
Total Receivables
CA$337k
CAGR 3-Years
-16%
CAGR 5-Years
2%
CAGR 10-Years
-6%

See Also

What is Aurinia Pharmaceuticals Inc's Total Receivables?
Total Receivables
36.5m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Total Receivables amounts to 36.5m USD.

What is Aurinia Pharmaceuticals Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
80%

Over the last year, the Total Receivables growth was -4%. The average annual Total Receivables growth rates for Aurinia Pharmaceuticals Inc have been 55% over the past three years , 136% over the past five years , and 80% over the past ten years .

Back to Top